Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Matthew Madin-Warburton
46  Ergebnisse:
Personensuche X
?
1

Cost-effectiveness of pembrolizumab for previously treated ..:

McCarthy, Grant ; Young, Kate ; Madin-Warburton, Matthew...
Journal of Medical Economics.  27 (2024)  1 - p. 279-291 , 2024
Link: https://doi.org/10.1080/..
 
?
2

Recent advances in addressing the market failure of new ant..:

Schurer, Marieke ; Patel, Renu ; van Keep, Marjolijn...
Frontiers in Medical Technology.  5 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
3

The Cost Effectiveness of Levodopa-Carbidopa Intestinal Gel..:

Chaudhuri, K. Ray ; Pickard, A. Simon ; Alobaidi, Ali...
PharmacoEconomics.  40 (2022)  5 - p. 559-574 , 2022
Link: https://doi.org/10.1007/..
 
?
4

Burden of Clostridioides difficile infection (CDI) - a syst..:

Finn, Elaine ; Andersson, Fredrik L. ; Madin-Warburton, Matthew
BMC Infectious Diseases.  21 (2021)  1 - p. , 2021
Link: https://doi.org/10.1186/..
 
?
5

1427. A Dynamic Modeling Study of the Effect of Introducing..:

Madin-Warburton, Matthew ; Pitcher, Ashley B ; Kyaw, Moe H.
Open Forum Infectious Diseases.  5 (2018)  suppl_1 - p. S440-S441 , 2018
Link: https://doi.org/10.1093/..
 
?
6

Cost-Effectiveness Analysis of Regorafenib for Gastrointest..:

Tamoschus, David ; Draexler, Katja ; Chang, Jane...
Clinical Drug Investigation.  37 (2017)  6 - p. 525-533 , 2017
Link: https://doi.org/10.1007/..
 
?
7

Benchmarking the Cost per Person of Mass Treatment for Sele..:

Fitzpatrick, Christopher ; Fleming, Fiona M. ; Madin-Warburton, Matthew...
PLOS Neglected Tropical Diseases.  10 (2016)  12 - p. e0005037 , 2016
Link: https://doi.org/10.1371/..
 
?
8

Cost-effectiveness of pembrolizumab for previously treated ..:

Grant McCarthy ; Kate Young ; Matthew Madin-Warburton...
doi:10.6084/m9.figshare.25117347.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
9

Cost-effectiveness of pembrolizumab for previously treated ..:

Grant McCarthy ; Kate Young ; Matthew Madin-Warburton...
doi:10.6084/m9.figshare.25117347.v1.  , 2024
Link: https://doi.org/10.6084/..
 
?
10

Datasheet1_Recent advances in addressing the market failure..:

Marieke Schurer ; Renu Patel ; Marjolijn van Keep...
doi:10.3389/fmedt.2023.1010247.s001.  , 2023
Link: https://doi.org/10.3389/..
 
?
11

Recent advances in addressing the market failure of new ant..:

Marieke Schurer ; Renu Patel ; Marjolijn van Keep...
https://www.frontiersin.org/articles/10.3389/fmedt.2023.1010247/full.  , 2023
Link: https://doi.org/10.3389/..
 
?
12

Burden of Clostridioides difficile infection (CDI) - a syst..:

Elaine Finn ; Fredrik L. Andersson ; Matthew Madin-Warburton
https://doi.org/10.1186/s12879-021-06147-y.  , 2021
Link: https://doi.org/10.1186/..
 
?
13

Benchmarking the Cost per Person of Mass Treatment for Sele..:

Christopher Fitzpatrick ; Fiona M Fleming ; Matthew Madin-Warburton...
http://europepmc.org/articles/PMC5137870?pdf=render.  , 2016
Link: https://doi.org/10.1371/..
 
?
14

Additional file 1 of Burden of Clostridioides difficile inf..:

Elaine Finn (10836861) ; Fredrik L. Andersson (8829254) ; Matthew Madin-Warburton (3383582)
https://figshare.com/articles/journal_contribution/Additional_file_1_of_Burden_of_Clostridioides_difficile_infection_CDI_-_a_systematic_review_of_the_epidemiology_of_primary_and_recurrent_CDI/14634189.  , 2021
Link: https://doi.org/10.6084/..
 
?
15

Recent advances in addressing the market failure of new ant..:

Schurer, Marieke ; Patel, Renu ; van Keep, Marjolijn...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9969890/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
1-15